Pars plana vitrectomy Clinical Trials
6 recruitingProcedure
Not Applicable4Phase 41Phase 31
Showing 1–6 of 6 trials
Recruiting
Phase 3
Vitrectomy, Subretinal Tissue Plasminogen Activator (TPA) and Intravitreal Gas for Submacular Haemorrhage Secondary to Exudative (Wet) Age-related Macular Degeneration (TIGER).
Eye DiseasesMacular Degeneration, WetSub-Macular Hemorrhage
King's College Hospital NHS Trust210 enrolled36 locationsNCT04663750
Recruiting
Phase 4
Dropless Pars Plana Vitrectomy Study
Massachusetts Eye and Ear Infirmary168 enrolled1 locationNCT05331664
Recruiting
Not Applicable
Progression Suppression and Retinal Regression in VEGF-resistant AMD
Neovascular Age-related Macular Degeneration (AMD)
PharmaBio Corporation10 enrolled1 locationNCT07005323
Recruiting
Not Applicable
Caffeine and Cataract After Pars Plana Vitrectomy
Cataract
Vienna Institute for Research in Ocular Surgery74 enrolled1 locationNCT06358664
Recruiting
Not Applicable
REtinal Detachment Outcomes Study
Retinal Detachment
CHU de Quebec-Universite Laval560 enrolled1 locationNCT05863312
Recruiting
Not Applicable
Long-term Results of Two Surgical Methods for Scleral IOL Implantation and Fixation in Eyes Without Capsular Support: Yamane- Versus 4-flanged Technique
Lens LuxationIOL SubluxationIOL Opacification+1 more
Medical University of Vienna100 enrolled1 locationNCT06102109